144 related articles for article (PubMed ID: 26491856)
21. Molecule of the month. Eltrombopag.
Drug News Perspect; 2008; 21(6):344. PubMed ID: 18836592
[No Abstract] [Full Text] [Related]
22. Does eltrombopag really ENABLE SVR?
Leber A; Feld JJ
Gastroenterology; 2014 Feb; 146(2):339-42. PubMed ID: 24361434
[No Abstract] [Full Text] [Related]
23. Eltrombopag for thrombocytopenic patients with chronic HCV infection.
Maan R; Veldt BJ; Janssen HL
Gastroenterology; 2014 Jul; 147(1):254-5. PubMed ID: 24877871
[No Abstract] [Full Text] [Related]
24. Eltrombopag.
Bussel JB; Pinheiro MP
Cancer Treat Res; 2011; 157():289-303. PubMed ID: 21052963
[TBL] [Abstract][Full Text] [Related]
25. Eltrombopag for thrombocytopenic patients with hepatitis C virus infection and cirrhosis.
Ji F; Deng H; Li Z
Gastroenterology; 2014 Jul; 147(1):253-4. PubMed ID: 24877867
[No Abstract] [Full Text] [Related]
26. Eltrombopag treatment for severe refractory thrombocytopenia caused by pembrolizumab.
Song P; Zhang L
Eur J Cancer; 2019 Nov; 121():4-6. PubMed ID: 31522129
[No Abstract] [Full Text] [Related]
27. Immune thrombocytopenic purpura--from agony to agonist.
Schwartz RS
N Engl J Med; 2007 Nov; 357(22):2299-301. PubMed ID: 18046034
[No Abstract] [Full Text] [Related]
28. Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation.
Tanaka T; Inamoto Y; Yamashita T; Fuji S; Okinaka K; Kurosawa S; Kim SW; Tanosaki R; Fukuda T
Biol Blood Marrow Transplant; 2016 May; 22(5):919-24. PubMed ID: 26785333
[TBL] [Abstract][Full Text] [Related]
29. [Eltrombopag for thrombocytopenia in 24 children after hematopoietic stem cell transplantation].
Liu S; Que LP; Huang K; Fang JP; Wang KM; Zhan LP; Liu DD; Xu HG
Zhonghua Er Ke Za Zhi; 2021 Apr; 59(4):311-315. PubMed ID: 33775051
[No Abstract] [Full Text] [Related]
30. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
McHutchison JG; Dusheiko G; Shiffman ML; Rodriguez-Torres M; Sigal S; Bourliere M; Berg T; Gordon SC; Campbell FM; Theodore D; Blackman N; Jenkins J; Afdhal NH;
N Engl J Med; 2007 Nov; 357(22):2227-36. PubMed ID: 18046027
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.
Tang C; Chen F; Kong D; Ma Q; Dai H; Yin J; Li Z; Chen J; Zhu X; Mao X; Wu D; Tang X
J Hematol Oncol; 2018 Aug; 11(1):103. PubMed ID: 30115080
[TBL] [Abstract][Full Text] [Related]
32. Economic assessment of eltrombopag in the treatment of thrombocytopenia.
Romano F; Ruggeri M; Coretti S; Giannini EG; Sacchini D; Annichiarico BE; Marchetti M; Rodeghiero F; Lidonnici D
Expert Rev Pharmacoecon Outcomes Res; 2015; 15(4):713-20. PubMed ID: 26176754
[TBL] [Abstract][Full Text] [Related]
33. New thrombopoietic agents: introduction.
Bussel JB; Kuter DJ
Semin Hematol; 2010 Jul; 47(3):211. PubMed ID: 20620430
[No Abstract] [Full Text] [Related]
34. Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation.
Zhou M; Li T; Zhang P; Lai Y; Sheng L; Ouyang G
Ann Hematol; 2024 May; 103(5):1697-1704. PubMed ID: 38536476
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation.
Rivera D; Bastida JM; Lopez-Corral L; Sanchez-Guijo F; Cabrero M; Martin A; Perez E; Lopez-Parra M; Avendaño A; Veiga A; Baile M; Arratibel N; Carrillo J; Vazquez L; Caballero MD; Gonzalez-Porras JR
Bone Marrow Transplant; 2019 May; 54(5):757-761. PubMed ID: 30356164
[No Abstract] [Full Text] [Related]
36. Current status of thrombopoietic agents.
Rhodes E; Stasi R
Expert Rev Hematol; 2010 Apr; 3(2):217-25. PubMed ID: 21083464
[TBL] [Abstract][Full Text] [Related]
37. First successful use of eltrombopag before surgery in a child with MYH9-related thrombocytopenia.
Favier R; Feriel J; Favier M; Denoyelle F; Martignetti JA
Pediatrics; 2013 Sep; 132(3):e793-5. PubMed ID: 23940247
[TBL] [Abstract][Full Text] [Related]
38. Eltrombopag as first-line treatment for thrombocytopenia among paediatric patients after allogeneic haematopoietic stem cell transplantation.
Qiu KY; Liao XY; Huang K; Wu RH; Xu HG; Xu LH; Li Y; Weng WJ; Zhou DH; Fang JP
Br J Clin Pharmacol; 2021 Apr; 87(4):2023-2031. PubMed ID: 33080064
[TBL] [Abstract][Full Text] [Related]
39. Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy.
Afdhal NH; Dusheiko GM; Giannini EG; Chen PJ; Han KH; Mohsin A; Rodriguez-Torres M; Rugina S; Bakulin I; Lawitz E; Shiffman ML; Tayyab GU; Poordad F; Kamel YM; Brainsky A; Geib J; Vasey SY; Patwardhan R; Campbell FM; Theodore D
Gastroenterology; 2014 Feb; 146(2):442-52.e1. PubMed ID: 24126097
[TBL] [Abstract][Full Text] [Related]
40. Eltrombopag in thrombocytopenia.
Zimmer J; Hentges F; Andrès E
N Engl J Med; 2008 Mar; 358(10):1072; author reply 1072-3. PubMed ID: 18326076
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
